Receive emails about upcoming NOVA programs and related content, as well as featured reporting about current events through a science lens. That may come as a surprise to those who associate ...

Q3 2025 Management View CEO Ramy Farid reported "very solid progress during the third quarter," highlighting total revenue of ...

Market conditions remain tough, which is weighing on demand for both Schrödinger's software and drug discovery services. Investors continue to punish Schrödinger's investments in drug discovery, ...

Schrödinger's Q4 2024 results and 2025 guidance were solid, yet the company's share price remains low due to ongoing losses. Cash burn is likely to moderate going forward, as investments in the ...

In physics, Schrödinger's cat is a thought experiment in which a cat is trapped in a box with a particle that has a 50-50 ...

Inside a box, there is a cat. It may be dead or it may be alive, because also in that small space is a vial of poisonous gas that has a 50/50 chance of releasing its destruction upon kitty. But no one ...

Physicists have placed part of a sapphire crystal into a quantum superposition, making it the heaviest object to show quantum effects, in a new take on Erwin Schrödinger's famous cat experiment. When ...

A group of modern physicists released a YouTube video starring the internet's favourite animal to explain Erwin Schrödinger's famous thought experiment for his 127th birthday. Born in 1887, ...

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, is providing a detailed review of ...

Yale physicists have given Schrödinger’s famous cat a second box to play in, and the result may help further the quest for reliable quantum computing. Schrödinger’s cat is a well-known paradox that ...

On November 29, 2015, cat lovers and haters will have common cause to celebrate. That date marks the 80th anniversary of the publication of Austrian physicist Erwin Schrödinger’s extraordinary paper ...

Eli Lilly has joined Schrödinger’s growing stable of drug development partners, putting up $425 million in milestones to access small-molecule candidates against an undisclosed target. Schrödinger has ...